Immunological predictors of CD4+ T cell decline in antiretroviral treatment interruptions
-
* Corresponding author: Ma Ángeles Muñoz-Fernández mmunoz.hgugm@salud.madrid.org
BMC Infectious Diseases 2008, 8:20 doi:10.1186/1471-2334-8-20
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 27 Aug 2007 | |
| Reviewer's Report | Jonathan Angel | 09 Oct 2007 | |
| Reviewer's Report | Daniel Skiest | 11 Oct 2007 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 09 Dec 2007 |
| Reviewer's Report | Daniel Skiest | 03 Jan 2008 | |
| Reviewer's Report | Jonathan Angel | 08 Jan 2008 | |
| Resubmission - Version 3 | Manuscript | Author's comment | 05 Feb 2008 |
| Resubmission - Version 4 | Manuscript | Author's comment | 06 Feb 2008 |
| Editorial acceptance | 15 Feb 2008 | ||
| Published | 26 Feb 2008 |